KRYS
Krystal Biotech Seizes Moment of Opportunity as VYJUVEK Achieves Record Revenue Growth
The first quarter 2026 conference call for Krystal Biotech, Inc. was a momentous occasion for the company, marking a decade since its inception. Chairman and Chief Executive Officer Krish Krishnan shared his excitement about the next 12 to 24 months being one of the most thrilling periods in Krystal'